Literature DB >> 6840853

Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants.

I Morisaki, S M Michalek, C C Harmon, M Torii, S Hamada, J R McGhee.   

Abstract

In the present study, we compared the ability of the soluble adjuvants concanavalin A (ConA), muramyl dipeptide (MDP), and peptidoglycan (PG) to enhance immune responses to orally administered particulate antigens of Streptococcus mutans 6715 in gnotobiotic rats. The isotype and levels of antibody in saliva and in serum from experimental rats were determined by an enzyme-linked immunosorbent assay using S. mutans whole cells (WC) as the coating antigen. The specificities of salivary and serum immunoglobulin A (IgA) antibodies to particulate S. mutans antigens, lipoteichoic acid, S. mutans serotype g carbohydrate, and dextran were also determined. When 50 micrograms of ConA was used as the oral adjuvant with S. mutans 6715 WC immunogen, a slight enhancement of immune responses was obtained. A higher dose of ConA suppressed humoral responses to the immunogen. Enhanced immune responses, especially of the IgA isotype, in both serum and saliva were induced in gnotobiotic rats given MDP and either S. mutans 6715 WC or purified cell walls (CW) by gastric intubation. Elevated IgA antibody levels to CW, lipoteichoic acid, and carbohydrate were observed in rats given S. mutans WC and MDP by gastric intubation, whereas oral immunization with S. mutans CW and MDP resulted in higher antibody levels to CW and carbohydrate and lower levels to lipoteichoic acid when compared with the antibody levels in rats given antigen alone. Rats orally immunized with either S. mutans WC or CW and MDP and challenged with virulent S. mutans 6715 exhibited significantly (P less than or equal to 0.05) lower plaque scores, numbers of viable S. mutans in plaque, and caries scores than did rats immunized with antigen alone or in infected-only controls. In another series of experiments, a PG fraction derived from S. mutans 6715 CW was assessed for adjuvant properties. The oral administration of PG and either S. mutans WC or CW induced good salivary and serum IgA antibody responses. The specificity of the antibodies was similar to that obtained in rats given antigen and MDP. Rats receiving either S. mutans WC or CW and PG and challenged with virulent S. mutans 6715 had lower plaque scores, fewer numbers of viable S. mutans in plaque, and lower caries activity than did infected rats receiving S. mutans WC or CW immunogen alone. These results provide evidence that soluble adjuvants derived from the gram-positive bacterial CW, e.g., MDP and PG, are effective oral adjuvants and augment IgA immune responses to particulate S. mutans antigens which are protective against the mucosally associated disease, dental caries.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840853      PMCID: PMC264894          DOI: 10.1128/iai.40.2.577-591.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

2.  Association of Streptococcus mutants with human dental decay.

Authors:  W J Loesche; J Rowan; L H Straffon; P J Loos
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

3.  Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity.

Authors:  S M Michalek; J R McGhee; J Mestecky; R R Arnold; L Bozzo
Journal:  Science       Date:  1976-06-18       Impact factor: 47.728

4.  Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.

Authors:  I Löwy; C Bona; L Chedid
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

5.  Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

6.  Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity.

Authors:  C Damais; C Bona; L Chedid; J Fleck; C Nauciel; J P Martin
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

7.  The secretory antibody response. Anti-DNP antibodies induced by dinitrophenylated type 3 pneumococcus.

Authors:  P C Montgomery; B R Rosner; J Cohn
Journal:  Immunol Commun       Date:  1974

8.  Studies on cell walls of group A Streptococcus pyogenes, type 12. II. Pyrogenic and related biological activities of the higher molecular weight fraction of an enzymatic digest of the cell walls.

Authors:  S Hamada; T Narita; S Kotani; K Kato
Journal:  Biken J       Date:  1971-09

9.  Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with Streptococcus mutans.

Authors:  S M Michalek; J Webb; J M Navia; A F Rahman; D W Legler
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  Effects of local immunization with glucosyltransferase fractions from Streptococcus mutans on dental caries in rats and hamsters.

Authors:  M A Taubman; D J Smith
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

View more
  20 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits.

Authors:  T Fukuizumi; H Inoue; T Tsujisawa; C Uchiyama
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Recent advances in the development of a Streptococcus mutans vaccine.

Authors:  J P Klein; M Scholler
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

4.  Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene.

Authors:  M Iwaki; N Okahashi; I Takahashi; T Kanamoto; Y Sugita-Konishi; K Aibara; T Koga
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  Oral immunization against Helicobacter pylori.

Authors:  S J Czinn; J G Nedrud
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

6.  Local and systemic immune response to orally administered liposome-associated soluble S. mutans cell wall antigens.

Authors:  D Wachsmann; J P Klein; M Schöller; R M Frank
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

7.  Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes.

Authors:  R L Gregory; S M Michalek; G Richardson; C Harmon; T Hilton; J R McGhee
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

8.  Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces.

Authors:  S Jackson; J Mestecky; N K Childers; S M Michalek
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction.

Authors:  R T Evans; B Klausen; H T Sojar; G S Bedi; C Sfintescu; N S Ramamurthy; L M Golub; R J Genco
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.